The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.

Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.

In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.

Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.

Ann Aerts has stared death in the eye. The head of the non-profit Novartis Foundation lost colleagues when she was serving as an emergency medicine physician on a medical mission in a dangerously unstable country.

After 40 years of working in information technology, Jim Barrington took a partial retirement from his job as Novartis’ chief information officer and started looking for new ways to apply his skills.

Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.

Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.